← Open Payments lookup

NATALIE BLANCHARD: Open Payments

NPI 1558846568 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,330 in 28 payments from 9 companies in 2025. Trend: 2023 $1,118 · 2024 $831 · 2025 $1,330

Food & beverage: $1,330
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$321
Janssen Biotech, Inc.2$237
ABBVIE INC.6$183
Boston Scientific Corporation2$170
Takeda Pharmaceuticals U.S.A., Inc.4$157
Gilead Sciences, Inc.1$94
GENZYME CORPORATION1$81
Ardelyx, Inc.2$58
Intercept Pharmaceuticals, Inc.1$30

Products named: REZDIFFRA, TREMFYA, ENTYVIO, Livdelzi, EXALT Model D, DUPIXENT, General - Biliary Devices, LINZESS.

Industry payments across ME — which companies pay providers there.